Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Silver Bullet Creates Credibility

Finding credibility It is very difficult for a new issuer to find goodwill in the capital markets. Historically, and we all have a story to add to this, not every company has told the truth or, in some cases, even known what the truth was, leading to jaded hearts, apathet...

Copper-gold deposits to help gold miners overcome depletion dilemma

Every fiscal quarter the World Gold Council puts out a wonderful little report on the gold market, that is made into an article by just about every mining news outlet. For reasons unknowable to mere mortals like us, the report focuses on gold demand. The reader has to go dee...

Saville reports impressive niobium drill results from Quebec, ...

Saville reports impressive niobium drill results from Quebec, outshining previous holes and other niobium projects globally Full size / Thumbs up for Saville Resources‘ President, Mike Hodge, and his hands-on organization of a successful winter drill program at...

Surface Oncology Shares Trade Up 40% on Phase1 Study Plans for SRF617 Combined with Merck's KEYTRUDA

Shares of Surface Oncology set a new 52-week high price after the company reported that it is partnering with Merck & Co. in an immuno-oncology study of SRF617, targeting CD39 in combination with KEYTRUDA® (pembrolizumab) in solid tumor patients. Clinical-...

Will the US Solar energy industry survive the COVID-19 crisis?

There are hardly any sectors not affected by Covid-19, including the US solar industry. The US solar industry is affected by compounding issues, delays in supply chains, strengthening the tax equity market, financial concerns of homeowners, shelter-in-place orders, and challen...

HAEMATO, MBH Corporation, USU Software - on the right path in 2020

The year 2020 will be a special year. The Corona Pandemic has turned many industries upside down. The travel industry and restaurants, for example, have enormous challenges to overcome and many companies will not make it despite government support. However, there are also busi...

The promise of AI

In ‘The Terminator’ series of action films starring Arnold Schwarzenegger, a cybernetic organism (cyborg) is programmed from the future to go back in time and kill the mother of the scientist who leads the fight against Skynet, an artificial intelligence syst...

Opportunities in the Aftermath of Yesterday’s Bloodbath

Tuesday’s session brought us another day of strong selling that overpowered whatever buying attempts emerged. And it turned out that yesterday’s premarket upswing was the key one. Before the closing bell, stocks slid through not one, but two imp...

This Key Resistance Breakout Is Where the Rubber Meets the Road

Tuesday’s refusal of the stock upswing didn’t really stick, and the S&P 500 opened higher. Trading with an upward bias during the session, the index closed comfortably above the 61.8% Fibonacci retracement. As outlandish as it might seem, does i...

Downward Reversal in Oil Is Knocking on the Door

Crude oil hasn’t closed higher yesterday and the previous series of rallies appears to face stiff headwinds. Is this it, or can the oil bulls pull a rabbit out of their hats? After all, they’ve reversed Monday’s downswing already...
1 2 3 4 5 6 7 8 9 10